Overexpression of T-box Transcription Factor 5 (TBX5) Inhibits Proliferation and Invasion in Non-Small Cell Lung Carcinoma Cells

Author:

Ma Ruoting1,Yang Yu1,Tu Qiuyun2,Hu Ke3

Affiliation:

1. Department of Senile Disease, The Second Xiangya Hospital, Central South University, Changsha, Hunan, P.R. China

2. Department of Senile Disease, The Third Xiangya Hospital, Central South University, Changsha, Hunan, P.R. China

3. Department of Clinical Medicine, Hunan University of Medicine, Changsha, Hunan, P.R. China

Abstract

T-box transcription factor 5 (TBX5), a member of the conserved T-box transcription factor family that functions in organogenesis and embryogenesis, has recently been identified as a critical player in cancer development. The aim of this study was to determine the role of TBX5 in non-small cell lung carcinoma (NSCLC). Immunohistochemistry was used to detect the correlation between levels of TBX5 and clinicopathological features of NSCLC patients in tissue microarray. Expression of TBX5 in NSCLC tissues and cell lines was evaluated by quantitative PCR and Western blot. The role of TBX5 in regulating proliferation, colony formation, invasion, and apoptosis of NSCLC cells was evaluated in vitro. Finally, a tumorigenicity assay was performed to determine the effect of TBX5 on tumor growth in vivo. The levels of TBX5 in NSCLC tissues were significantly correlated with the TNM stage (p = 0.016), histopathologic type (p = 0.029), and lymph node status (p = 0.035) of NSCLC. TBX5 overexpression markedly suppressed in vitro NSCLC cell proliferation, colony formation, and invasion and induced apoptosis. In vivo tumor growth was significantly suppressed by TBX5. TBX5 has a tumor-suppressing effect in NSCLC and may serve as a therapeutic target for diagnoses and treatment of NSCLC.

Publisher

Cognizant, LLC

Subject

Cancer Research,Oncology,General Medicine

Reference27 articles.

1. Gene expression profiling for early-stage NSCLC;Am J Clin Oncol.,2015

2. Expression of G protein-coupled receptor 56 is associated with tumor progression in non-small-cell lung carcinoma patients;Onco Targets Ther.,2016

3. Expression and prognostic relevance of MET and phospho-BAD in non-small cell lung cancer;Onco Targets Ther.,2013

4. Tumor markers in detection of lung cancer;Adv Clin Chem.,2006

5. Serum markers in small cell lung cancer: Opportunities for improvement;Biochim Biophys Acta,2013

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3